Sixty to seventy percent of MDD patients improve with psychotherapy and drugs; remaining 30 percent require alternative treatments like ketamine, psilocybin, ECT, and brain stimulation.
World's First: FDA Approves Flow Neuroscience Device as First At-Home Brain Stimulation Treatment for Depression
Flow Neuroscience's FDA-approved at-home tDCS device provides a prescribable non-drug treatment option for adults with moderate to severe major depressive disorder.
Psychotic depression causes delusions or hallucinations during major depressive episodes, producing extreme suffering but responding to safe, effective treatments.